These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Healthcare Resource Utilization and Costs in Celiac Disease: A US Claims Analysis. Cappell K; Taylor A; Johnson BH; Gelwicks S; Wang S; Gerber M; Leffler DA Am J Gastroenterol; 2020 Nov; 115(11):1821-1829. PubMed ID: 33156101 [TBL] [Abstract][Full Text] [Related]
23. Administrative coding is specific, but not sensitive, for identifying eosinophilic esophagitis. Rybnicek DA; Hathorn KE; Pfaff ER; Bulsiewicz WJ; Shaheen NJ; Dellon ES Dis Esophagus; 2014; 27(8):703-8. PubMed ID: 24215617 [TBL] [Abstract][Full Text] [Related]
24. Impact of metastatic colorectal cancer stage and number of treatment courses on patient health care costs and utilization. Chastek B; Kulakodlu M; Valluri S; Seal B Postgrad Med; 2013 Mar; 125(2):73-82. PubMed ID: 23816773 [TBL] [Abstract][Full Text] [Related]
25. Wilson's Disease: An Analysis of Health Care Use and Cost Burden of Commercially Insured Adults in the United States. Rustgi VK; Gupta K; Tait C; Bhurwal A; Kabaria S; Catalano C; Li Y; Minacapelli CD Hepatol Commun; 2022 Feb; 6(2):389-398. PubMed ID: 34559472 [TBL] [Abstract][Full Text] [Related]
26. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Coyne KS; Paramore C; Grandy S; Mercader M; Reynolds M; Zimetbaum P Value Health; 2006; 9(5):348-56. PubMed ID: 16961553 [TBL] [Abstract][Full Text] [Related]
27. The Economic Burden of Asthma in the United States, 2008-2013. Nurmagambetov T; Kuwahara R; Garbe P Ann Am Thorac Soc; 2018 Mar; 15(3):348-356. PubMed ID: 29323930 [TBL] [Abstract][Full Text] [Related]
28. Economic burden of major bleeding events in commercially insured patients with von Willebrand disease based on claims data from the United States. Lu M; Oladapo A; Wu Y; Farahbakhshian S; Ewenstein B J Manag Care Spec Pharm; 2021 Feb; 27(2):175-185. PubMed ID: 33307935 [No Abstract] [Full Text] [Related]
29. Disease Burden and Treatment Patterns Associated With Eosinophilic Esophagitis in the United States: A Retrospective Claims Study. Lu M; Goodwin B; Vera-Llonch M; Williams J J Clin Gastroenterol; 2022 Feb; 56(2):133-140. PubMed ID: 33443967 [TBL] [Abstract][Full Text] [Related]
30. A two-part model to estimate inpatient, outpatient, prescribing and care home costs associated with atrial fibrillation in Scotland. Ciminata G; Geue C; Langhorne P; Wu O BMJ Open; 2020 Mar; 10(3):e028575. PubMed ID: 32193256 [TBL] [Abstract][Full Text] [Related]
31. Hospitalization trends and determinants of inpatient costs for eosinophilic esophagitis patients in the United States: results from the Nationwide Inpatient Sample analysis. Eke R; Dellon ES Ann Gastroenterol; 2021; 34(5):643-650. PubMed ID: 34475734 [TBL] [Abstract][Full Text] [Related]
32. Transnasal Endoscopy in Unsedated Children With Eosinophilic Esophagitis Using Virtual Reality Video Goggles. Nguyen N; Lavery WJ; Capocelli KE; Smith C; DeBoer EM; Deterding R; Prager JD; Leinwand K; Kobak GE; Kramer RE; Menard-Katcher C; Furuta GT; Atkins D; Fleischer D; Greenhawt M; Friedlander JA Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2455-2462. PubMed ID: 30708107 [TBL] [Abstract][Full Text] [Related]
34. Descriptive analysis of the direct medical costs of multiple sclerosis in 2004 using administrative claims in a large nationwide database. Prescott JD; Factor S; Pill M; Levi GW J Manag Care Pharm; 2007; 13(1):44-52. PubMed ID: 17269836 [TBL] [Abstract][Full Text] [Related]
35. A diagnosis of eosinophilic esophagitis is associated with increased life insurance premiums. Leiman DA; Kochar B; Posner S; Fan C; Patel A; Shaheen O; Keller CY; Koutlas NT; Eluri S; Dellon ES Dis Esophagus; 2018 Aug; 31(8):. PubMed ID: 29800243 [TBL] [Abstract][Full Text] [Related]
36. Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data. Margolis J; Barron JJ; Grochulski WD J Manag Care Pharm; 2005; 11(9):727-34. PubMed ID: 16300416 [TBL] [Abstract][Full Text] [Related]
37. The Economic Burden of Pediatric Asthma in the United States: Literature Review of Current Evidence. Perry R; Braileanu G; Palmer T; Stevens P Pharmacoeconomics; 2019 Feb; 37(2):155-167. PubMed ID: 30315512 [TBL] [Abstract][Full Text] [Related]
39. The impact of obesity on health service utilization and costs in childhood. Trasande L; Chatterjee S Obesity (Silver Spring); 2009 Sep; 17(9):1749-54. PubMed ID: 19300433 [TBL] [Abstract][Full Text] [Related]
40. Is There a Role for pH Impedance Monitoring in Identifying Eosinophilic Esophagitis in Children with Esophageal Atresia? Pesce M; Krishnan U; Saliakellis E; Lopez R; Lindley KJ; Thapar N; Borrelli O J Pediatr; 2019 Jul; 210():134-140. PubMed ID: 31036410 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]